Priority Date: 26.06.12 (US 201261664279P)

METHODS FOR TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS EMPLOYING DIANHYDROGALACTITOL, DIACETYLDIANHYDROGALACTITOL, DIBROMODULCITOL, OR ANALOGS OR DERIVATIVES THEREOF

  • Application ID: EP13809749
  • Status: GRANT OF PATENT INTENDED

Attorney

operating since 1896
Headquarters in Munich, Hamburg, Berlin
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 26.06.2012 - Priority Date (US 201261664279P)
  • 03.01.2014 - Publication A2 (WO2014004376)
  • 20.05.2015 - Publication A2 (EP2872161)

IPC Classification